Evidence map›Paper›PMID 33027964›Full record

ArticleMolecules (Basel, Switzerland)2020

4-Oxatricyclo[5.2.1.0

Ayodeji O Egunlusi, Sarel F Malan, Sylvester I Omoruyi, Okobi E Ekpo, Jacques Joubert

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. 4-Oxatricyclo[5.2.1.0Molecules (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ayodeji O EgunlusiPharmaceutical Chemistry, School of Pharmacy, University of the Western Cape, Private Bag X17, Bellville 7535, South Africa.ORCID 0000-0003-2251-6043
Sarel F MalanPharmaceutical Chemistry, School of Pharmacy, University of the Western Cape, Private Bag X17, Bellville 7535, South Africa.ORCID 0000-0002-1640-6457
Sylvester I OmoruyiDepartment of Medical Biosciences, University of the Western Cape, Private Bag X17, Bellville 7535, South Africa.ORCID 0000-0002-1119-7780
Okobi E EkpoDepartment of Medical Biosciences, University of the Western Cape, Private Bag X17, Bellville 7535, South Africa.ORCID 0000-0003-3193-7499
Jacques JoubertPharmaceutical Chemistry, School of Pharmacy, University of the Western Cape, Private Bag X17, Bellville 7535, South Africa.ORCID 0000-0003-0378-7091
University of the Western Cape · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The impact of excitotoxicity mediated by

Indexed as

Calcium Channel BlockersCalcium ChannelsMolecular Docking SimulationNeuronsNeuroprotective AgentsReceptors, N-Methyl-D-AspartateCell Line, TumorDose-Response Relationship, DrugHumansNeurodegenerative DiseasesCalcium Channel BlockersCalcium ChannelsNeuroprotective AgentsReceptors, N-Methyl-D-Aspartate4-oxatricyclo[5.2.1.02,6]dec-8-ene-3,5-dionecytotoxicityneurodegenerative disordersneuroprotectionNMDA receptorpolycyclic cagesvoltage gated calcium channels

Identifiers

PMID33027964
PMCPMC7582567
OpenAlexW3091158341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.